1. Stem Cell Therapy

Category Archives: Stem Cell Therapy

Dr. Raj, Top Beverly Hills Orthopedic Doctor, Appears on The Doctors TV Show Performing Successful Stem Cell Therapy

Posted on by

Beverly Hills, California (PRWEB) April 13, 2015

Dr. Raj, who is the top orthopedic surgeon in Los Angeles and Beverly Hills, appeared on The Doctors TV show this week performing successful stem cell therapy. The patient received an outpatient stem cell procedure for bilateral labral tears in the shoulders, with an incredible outcome displayed on the show.

The segment can be viewed here: http://www.thedoctorstv.com/videos/stem-cells-instead-of-surgery

For years, Dr. Raj has been helping patients avoid invasive surgeries with outpatient, low risk stem cell procedures. The focus of the segment on The Doctors was a patient who was having severe functional limitations due to her shoulder injuries. She could not drive without pain or do any regular activities such as brushing her hair or reaching overhead without immediate pain.

While being interviewed on the show four days after the procedure, Jennifer stated, "This is crazy. What's really shocking is I can put my arms above my head, I haven't done that in 10 years!"

Dr. Raj, as he has done for hundreds of patients, first aspirated some of the patients bone marrow. Then the marrow was processed immediately to concentrate the stem cells and growth factors. The processed marrow was then injected bilaterally into her shoulders along with numbing medicine, and then the procedure was done.

After four days the patient appeared with Dr. Raj on the show. She was able to painlessly drive, lift her arms above her head, and was truly amazed at the outcome in such a short time. Dr. Raj was asked if her result was typical.

He replied, "Stem cells are so magical. I've seen this frequently, it is expected."

Host Dr. Travis Stork then said, "I'm a fan if you can avoid a true surgery. It's all about the beauty of more options. This just adds another option in the arsenal."

For over 5 years, Dr. Raj has been named a Top Doctor in Southern California, Beverly Hills, Los Angeles and Nationally as well. He serves as an ABC News Medical Correspondent as well as a WebMD expert. National newspapers and television networks often turn to Dr. Raj for perspective on orthopedic injuries and treatments.

Follow this link:

Dr. Raj, Top Beverly Hills Orthopedic Doctor, Appears on The Doctors TV Show Performing Successful Stem Cell Therapy

Mesoblast takes partnership with Celgene, shares rise 27pc

Posted on by

Mesoblast chief executive Silviu Itescu says new strategic partner Celgene has a "strong franchise and sales and marketing. Photo: Josh Robenstone

Mesoblast chief executive Silviu Itescu says a $58.5 million investment from pharmaceutical giant Celgene gives the company a strong potential route to market as the stem cell therapy developernears its first sales.

The American giant Celgene, which had revenue of $US7.7 billion ($10 billion) from treatments for cancers and inflammatory diseases like psoriasis, picked up 15.3 million shares at $3.82 a share. Investors welcomed the deal, pushing the volatile stock up 24 per cent to $3.99 on Monday.

The surge boosted the value of Mr Itescu's 22 per cent stake in the company by $53 million to $272 million.

Mesoblast shares have lost about 16 per cent in the past year, compared with a 10 per cent rise in the benchmark S&P/ASX 200 index.

The stock last traded at the placement price a month ago, but has traded as high as $5.75 in the past year. Mr Itescu said Mesoblast and Celgene began talks about six months ago. He described the deal as "a fair transaction".

"The right time is when you come to an arrangement with a strategic partner," he said. "Where the share price is at any given time is much less relevant to the value of the technology and the partnership."

As part of the deal, which gives Celgene a stake of about 4.5 per cent, the company will have first right of refusal over licensing deals for the commercialisation of Mesoblast's adult stem cell products in the treatment of certain diseases.

That is, if Mesoblast is approached by another company to licence itsdrug candidates for the prevention and treatment of acute graft versus host disease (GVHD), certain oncologic diseases, inflammatory bowel diseases, and organ transplant rejection, Celgene will have six months in which it can mull whether it would like to trump the deal.

Mr Itescu said Celgene has a "strong franchise and sales and marketing capability" in cancer and inflammatory diseases. He said Mesoblast's candidate for the treatment of graft versus host disease, a common complication of bone marrow transplants used to treat cancer, "fits perfectly well into their cancer and oncology franchise."

Link:

Mesoblast takes partnership with Celgene, shares rise 27pc

Stem Cell Therapy For Pain – Columbia Pain Management, Hood River OR – Video

Posted on by


Stem Cell Therapy For Pain - Columbia Pain Management, Hood River OR
http://regenerativepaintherapy.com/ (541) 716-6469 Dr David Russo with Columbia Pain Management in Hood River, OR. announces a new treatment for acute and chronic pain. Using the Regenexx...

By: Trey Rigert

Read more here:

Stem Cell Therapy For Pain - Columbia Pain Management, Hood River OR - Video

What is Stem Cell Therapy- Trinity Spine and Wellness Center New Port Richey – Video

Posted on by


What is Stem Cell Therapy- Trinity Spine and Wellness Center New Port Richey
http://www.Trinity-Spine.com -727-372-9922 what is Stem Cell Therapy for back pain? Watch this video to see how Stem Cell Therapy can immediately help your chronic neck and back pain. Visit our website ...

By: Anderson Flanders

Read more:

What is Stem Cell Therapy- Trinity Spine and Wellness Center New Port Richey - Video

Stem Cell Therapy for Pain – Now Available at Columbia Pain Management – Video

Posted on by


Stem Cell Therapy for Pain - Now Available at Columbia Pain Management
http://regenerativepaintherapy.com Call: 541-716-6469 Columbia Pain Management Can Help You Get Your Life Back. Stem Cell Therapy for Pain - Now Available at Columbia Pain Management.

By: Trey Rigert

Go here to see the original:

Stem Cell Therapy for Pain - Now Available at Columbia Pain Management - Video

U.S. Stem Cell Clinic: How is Stem Cell Therapy Performed? – Video

Posted on by


U.S. Stem Cell Clinic: How is Stem Cell Therapy Performed?
Our U.S. Stem Cell Clinic will perform outpatient procedures using a process in which we isolate a patient #39;s own stem cells from either their own adipose fat tissue or bone marrow. Approximately...

By: U.S. Stem Cell Clinic

Read the original:

U.S. Stem Cell Clinic: How is Stem Cell Therapy Performed? - Video

U.S. Stem Cell Clinic: When should I expect to see results? – Video

Posted on by


U.S. Stem Cell Clinic: When should I expect to see results?
It is important to note that we are treating patients with their own adult stem cells, therefore each treatment and response is unique to that patient. No guarantee can be made of what results...

By: U.S. Stem Cell Clinic

See original here:

U.S. Stem Cell Clinic: When should I expect to see results? - Video

Most stem cell therapy at experimental stage: Scientist

Posted on by

New Delhi, April 11 (IANS): Though there are many stem cell therapies that are being explored, bone marrow transplant is the only one which has been tried and tested, a noted scientist has said.

Stem cell therapy is the use of stem cells to treat or prevent a disease or condition. Stem cells are undifferentiated cells of an organism which are capable of giving rise to indefinitely more cells of the same type, and from which certain other kinds of cells arise by differentiation.

"Most of the stem cell therapies like the ones which can successfully treat Parkinson's disease and methods of ortho-reconstruction are in experimental stages," noted cellular biologist Jyotsna Dhawan said in a special lecture on 'Stem cells: Myths and Realities' at the India International Centre (IIC) here Friday evening.

Dhawan, a senior scientist at the Centre for Cellular and Molecular Biology, Hyderabad, said stem cells are a potential source of repair of other tissues and can be very useful in treating genetic and inherited diseases. She said stem cells are specially useful in treating genetic disorders associated with blood like haemophilia and thalassemia.

"But, major ethical issues arise when embryonic stem cells (cells taken from a foetus) are used for therapy," she added.

On the many myths associated with stem cells, Dhawan said: "All these myths stem from the hope that we are able to tackle many of these diseases through stem cells".

Experiments are on to try and find cures for debilitating and terminal diseases like muscular dystrophy and cancer through stem cell therapy.

Stay updated wherever you go with Daijiworld.com and Daijiworld 24X7 tv channel mobile apps. CLICK HERE to download it for your device. (available on Android and IOS)

See more here:

Most stem cell therapy at experimental stage: Scientist

Regeneus hits key stem cell manufacturing milestone

Posted on by

(MENAFN - ProactiveInvestors)

Regeneus (ASX: RGS) has achieved a key milestone with the manufacture of its off-the-shelf stem cell therapy product Progenza for its First-in-Human trial for the treatment of osteoarthritis.

The company is on track to receive ethics approval and commence recruitment for the trial in the first-half of 2015.

Adding interest the company highlighted the benefit of using adipose or fat tissue over other tissue types by demonstrating the capacity to produce millions of therapeutic doses of Progenza from a single donor.

The production of commercial quantities of stem cells from a single donor is critical to maximise dose-to-dose consistency chief executive officer John Martin said.

This scale of production will minimise clinical trial and regulatory risks while reducing the cost of the final product.

One of the key advantages for manufacturing Progenza at industrial scale is that it uses stem cells sourced from adipose or fat tissue.

Adipose tissue is readily available from donors in large quantities and has significantly higher stem cells per gram of tissue than other tissue sources such as bone marrow or cord tissue.

Also adipose derived stem cells show greater capacity for expansion than stem cells from other tissue types.

Progenza adipose derived stem cells are adult stem cells they are not genetically modified like induced pluripotent stem cells (iPSC).

Read the original here:

Regeneus hits key stem cell manufacturing milestone

CryoStor Cell Preservation Selected For Phase III Clinical Trials of C-Cure Cell Therapy for Congestive Heart Failure

Posted on by

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues (BioLife or the Company), today announced that Cardio3 BioSciences, a leader in engineered cell therapy with clinical programs initially targeting indications in cardiovascular disease and oncology, has embedded the Companys clinical grade CryoStor cryopreservation freeze media in its ongoing Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) phase III clinical trial in Europe and Israel and the pending CHART-2 phase III clinical trial to be conducted in the United States.

CHART-1 (Congestive Heart Failure Cardiopoietic Regenerative Therapy) is a patient prospective, controlled multi-centre, randomized, double-blinded Phase III clinical trial comparing treatment with C-Cure to a sham treatment. The trial has recruited 240 patients with chronic advanced symptomatic heart failure. The primary endpoint of the trial is a composite endpoint including mortality, morbidity, quality of life, Six Minute Walk Test and left ventricular structure and function at nine months post-procedure.

Dr. Christian Homsy, CEO of Cardio3 BioSciences, commented on the selection of CryoStor by stating, We evaluated several possible freeze media formulations for our clinical cell therapy product development and manufacturing. CryoStor and BioLife best met our preservation efficacy, product and supplier quality, and customer support requirements.

As of January 2015, BioLife management estimates that the Companys CryoStor freeze media and HypoThermosol cell and tissue storage/shipping media have been incorporated into at least 175 customer clinical trials of novel cellular immunotherapies and other cell-based approaches for treating and possibly curing the leading causes of death and disorders throughout the world. Within the cellular immunotherapy segment of the regenerative medicine market, BioLife's products are embedded in the manufacturing, storage, and delivery processes of at least 75 clinical trials of chimeric antigen receptor T cells (CAR-T), T cell receptor (TCR), dendritic cell (DC), tumor infiltrating lymphocytes (TIL), and other T cell-based cellular therapeutics targeting solid tumors, hematologic malignancies, and other diseases and disorders. A large majority of the currently active private and publicly traded cellular immunotherapy companies are BioLife customers.

Mike Rice, BioLife Solutions CEO, remarked; We are honored to be able to supply our clinical grade CryoStor cell freeze media for Cardio3 Biosciences phase III clinical trials. Congestive heart failure is a leading cause of death and C-Cure is a novel and potentially life-saving, cell-based therapy that offers hope to millions of patients throughout the world. We are very well positioned to participate in the growth of the regenerative medicine market, with our products being used in at least 75 phase II and over 20 phase III clinical trials of new cell and tissue based products and therapies.

About Cardio3 Biosciences Cardio3 BioSciences is a leader in engineered cell therapy with clinical programs initially targeting indications in cardiovascular disease and oncology. Founded in 2007 and based in the Walloon region of Belgium, Cardio3 BioSciences leverages research collaborations in the USA with the Mayo Clinic (MN, USA) and Dartmouth College (NH, USA). The Companys lead product candidate in cardiology is C-Cure, an autologous stem cell therapy for the treatment of ischemic heart failure. The Companys lead product candidate in oncology is CAR- NKG2D, an autologous CAR T-cell product candidate using NKG2D, a natural killer cell receptor designed to target ligands present on multiple tumor types, including ovarian, bladder, breast, lung and liver cancers, as well as leukemia, lymphoma and myeloma. Cardio3 BioSciences is also developing medical devices for enhancing the delivery of diagnostic and therapeutic agents into the heart (CCath) and potentially for the treatment of mitral valve defects. Cardio3 BioSciences shares are listed on Euronext Brussels and Euronext Paris under the ticker symbol CARD. To learn more about Cardio3 BioSciences, please visit c3bs.com

Read the original:

CryoStor Cell Preservation Selected For Phase III Clinical Trials of C-Cure Cell Therapy for Congestive Heart Failure

Daily Digest: The horse stem cell fix is in for Colorado, and 9 other stories

Posted on by

Brenda Simmons hugs her horse Little Brother at her ranch in Granby late last month. Simmons and Little Brother have had stem cell therapy on their legs, preventing debilitating issues for both. (Andy Cross, The Denver Post)

Colorado Parks and Wildlife officers removed about 100 prairie dogs. (Courtesy Malia Reeves)

Your daily resource for late-breaking news, upcoming events, the Denver weather forecast, Denver traffic information, and the stories that will be talked about on Wednesday, April 8, 2015. Download our iPhone, iPad and Android apps for breaking news throughout the day.

1. THE HORSE FIX IS IN

The story of how researchers are using some horse sense to innovate stem cell joint therapies. Close to home, horses are leading humans into new territory, inspiring not only patients but researchers in regenerative therapies at Colorado State University in Fort Collins and the University of Colorado Hospital in Denver.

2. NOBLE TO CUT 100 ENERGY JOBS

Noble Energy, Colorado's second largest oil producer, said Tuesday that in the face of low prices it is reorganizing its operations cutting 100 jobs in Denver and Greeley.

3. 100 SEIZED PRAIRIE DOGS IN RODENT LIMBO

State wildlife agents and police officers seized about 100 prairie dogs from a Castle Rock woman's garage Tuesday morning, weeks after they were trapped at a controversial shopping mall development site.

4. POUNCED IN PRISON

See more here:

Daily Digest: The horse stem cell fix is in for Colorado, and 9 other stories

Colorado researchers use horse sense to innovate joint therapies

Posted on by

When Little Brother came up lame six years ago at the age of 8, Brenda Simmons took her horse from one veterinarian specialist to another to find a fix.

Injections of the horse's stem cells into a lower leg joint and tendons relieved his pain and returned full function to a horse that had been unridable.

"He was better than ever, and he's still going strong," the 58-year-old Granby resident said. "I asked the vet, 'Can you do that for me?' "

She couldn't, but a physician in Edwards, Dr. Scott Brandt, did treat her with stem cells.

After crippling pain had sidelined her for years, she said, injection of her own stem cells and other living cell products, taken from her bone marrow and fat tissue, has restored the former runner and skier to a more active life over the past year. She had already had one knee-replacement surgery, but she now believes she can avoid a second one.

( | )

"It's not mainstream. It's still in development," Brandt said of treatment that can cost $8,000 to $12,000 and isn't covered by insurance. "But it will happen in our lifetimes. This will delay or prevent many surgeries."

Many orthopedic specialists remain skeptical of these treatments unsure where proven advancements end and experimentation begins in doctors' offices using people's stem cells along with other biological components.

Yet leading researchers say there is real potential, especially if the Food and Drug Administration eases restrictions on culturing adult stem cells in labs for reinjection.

Even as these alternatives to surgical fixes for knees, backs, hips, shoulders and elbows are being developed, joint surgeries are booming as Americans resist being stiff and sore.

See the article here:

Colorado researchers use horse sense to innovate joint therapies

Okyanos Cell Therapy: From Burnout to Fearless

Posted on by

Freeport, Grand Bahama (PRWEB) April 08, 2015

Amy was searching for a way to get her type 1 diabetes under control when she was referred to Okyanos, the leader in cell therapy. After years of regular visits to the hospital for diabetes, neuropathy and fibromyalgia, she was looking for something that would help her lead a healthier, more normal life. No stranger to pain, Amy has had more than her share of treatments, including meditation, biofeedback, physical therapy and medications, getting her to a point of functional with very bad flare ups.

Amy experienced a condition called diabetes burnout which can occur when one gets tired of the endless attention diabetes care requires. After such a period, just 19 and a sophomore in college, Amy woke up one day with swollen feet and persistent horrible pain. She went home to Florida for spring break and ended up in the hospital for six weeks with a neuropathy diagnosis. Neuropathy is common in older diabetics but at a young age, the diagnosis threatened what shred of normal she had left.

I couldnt sleep with a blanket and it was hard to have anything on my feet. I had to shake the bed to distract myself from the pain. My life consisted of sitting in a bath tub for 6 hours a day running water over my feet, Amy explained.

After deciding to undergo adult stem cell therapy, Amy said her doctor was extremely encouraging and really interested. However, Amy stated, Nothing could prepare me for how nice the facility was. Everything was explained and when it came time for the procedure, I had no doubts. It was great.

After some initial hesitation and a set of expectations, Amy says she couldnt be happier with her results. I can now sleep with a blanket. I dont shake the bed the entire night. My feet arent a constant thought in the back of my mind anymore. The other day it was about 4pm and I realized, I havent thought about my feet once today, she shared.

In addition to changes in her daily life, Amys post-cell therapy successes are still coming in. When Amy saw her doctor a few weeks after treatment, and a regular check-up, they discovered Amys A1C levels (test to measure average blood glucose level) were significantly lower.

My doctor hadnt ever dealt with this kind of situation before. I think what really blew her mind was the fact that my A1C has gone down so much. Before the cell therapy, I was at 8.9. Now Im at a 7.8. I havent been that low in years, said a delighted Amy.

According to the American Diabetes Association, over 20 million diagnosed Americans suffer from diabetes and roughly 1.25 million are type 1. Diabetes remains the 7th leading cause of death in the US.

Adult stem cell therapy has emerged as a new treatment alternative for those with auto-immune conditions like diabetes and are restricted in activities they can no longer do but are determined to live a more normal life. Okyanos cell therapy uses a unique blend of adult stem and regenerative cells derived from a patients own fat tissue, thereby utilizing the bodys own natural biology to heal itself.

Go here to see the original:

Okyanos Cell Therapy: From Burnout to Fearless


  1. Stem Cell Therapy